Antibody Discovery News and Research

RSS
Antiverse raises £3.5 M ($4.6 M) to advance generative AI antibody design platform

Antiverse raises £3.5 M ($4.6 M) to advance generative AI antibody design platform

De novo antibody protein sequencing reveals novel functional and neutralizing antibodies post-SARS-CoV-2 vaccination

De novo antibody protein sequencing reveals novel functional and neutralizing antibodies post-SARS-CoV-2 vaccination

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Discovery of antibodies that boost complement activation against K. pneumoniae

Discovery of antibodies that boost complement activation against K. pneumoniae

Early specificity testing crucial for antibody drug safety

Early specificity testing crucial for antibody drug safety

Using deep learning to design synthetic soluble versions of cell membrane proteins

Using deep learning to design synthetic soluble versions of cell membrane proteins

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Antibody discovery could explain mysteries about COVID-19 and long COVID

Antibody discovery could explain mysteries about COVID-19 and long COVID

Rapid Novor and MAbSilico partner for world's first AI-guided epitope mapping service for antibodies

Rapid Novor and MAbSilico partner for world's first AI-guided epitope mapping service for antibodies

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

How next-gen sequencing is changing antibody drug discovery

How next-gen sequencing is changing antibody drug discovery

New Sartorius Digital Handbook brings the power of High-Throughput Screening (HTS) by cytometry to every scientist

New Sartorius Digital Handbook brings the power of High-Throughput Screening (HTS) by cytometry to every scientist

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

LabGenius & Sanofi partnership yields positive results from AI antibody discovery platform

LabGenius & Sanofi partnership yields positive results from AI antibody discovery platform

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

Unleashing the Power of Microfluidic Picodroplets

Unleashing the Power of Microfluidic Picodroplets

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.